Thomas Bieber
- Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phaseIIItrials
2020/01/30 by E.L. Simpson, Eric L. Simpson, J.‐P. Lacour +43 · 29 citations
Medicine · Immunology and Microbiology · #Dermatology and Skin Diseases #Psoriasis: Treatment and Pathogenesis #Allergic Rhinitis and Sensitization
- Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial*
2020/10/01 by Jonathan I. Silverberg, J.I. Silverberg, D. Toth +19 · 30 citations
Medicine · Immunology and Microbiology · #Dermatology and Skin Diseases #Psoriasis: Treatment and Pathogenesis #Allergic Rhinitis and Sensitization
- Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials
2023/03/30 by Andrew Blauvelt, Jacob P. Thyssen, Jacob P Thyssen +19 · 26 citations
Medicine · Immunology and Microbiology · #Dermatology and Skin Diseases #Psoriasis: Treatment and Pathogenesis #Asthma and respiratory diseases
- Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003
2004/05/01 by S.G.O Johansson, S. G. O. Johansson, Thomas Bieber +17 · 1 citation
Medicine · #Allergic Rhinitis and Sensitization #Asthma and respiratory diseases #Dermatology and Skin Diseases
- Emerging Biologic Therapies for the Treatment of Atopic Dermatitis
2024/10/04 by José Miguel Alvarenga, Thomas Bieber, Tiago Torres · 22 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Dermatology and Skin Diseases #Food Allergy and Anaphylaxis Research #Transgenic Plants and Applications